Calapkulu, M. Et Al. 2019. Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.13, no.2 , 1031-1034.

Calapkulu, M., CANDER, S., ÖZ GÜL, Ö., & ERSOY, C., (2019). Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.13, no.2, 1031-1034.

Calapkulu, Murat Et Al. "Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center," DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.13, no.2, 1031-1034, 2019

Calapkulu, Murat Et Al. "Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center." DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.13, no.2, pp.1031-1034, 2019

Calapkulu, M. Et Al. (2019) . "Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center." DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.13, no.2, pp.1031-1034.

@article{article, author={Murat Calapkulu Et Al. }, title={Lipid profile in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data of six months retrospective lipid profile from single center}, journal={DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS}, year=2019, pages={1031-1034} }